William Beacham
Obstetrics · Hammond, LANPI 1194728600
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Modernatx, Inc. at 55.4% of the total. 2024 is the largest year on record at $1,334, 4.1 times the $327 reported in 2019.
Across 66 payments — averaging $35.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$1K
- AbbVie$433
- Exeltis, USA Inc.$100
- Astellas Pharma US Inc$99
- Amgen$89
- Aspira Women's Health Inc$54
- plus $279 from 12 others
Across 3,500 payments — averaging $2580.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$5.6M
- Novavax Inc$1.4M
- Organon$1.1M
- Seqirus USA Inc$306K
- Currax Pharmaceuticals LLC$187K
- Pfizer$129K
- plus $247K from 5 others
What the payments were for
- Travel & lodging$95140%
- Food & beverage$1,31556%
- Education$984%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 13 | $1,310 |
| AbbVie | 22 | $433 |
| Exeltis, USA Inc. | 4 | $100 |
| Astellas Pharma US Inc | 2 | $99 |
| Amgen | 6 | $89 |
| Aspira Women's Health Inc | 1 | $54 |
| Mylan Pharmaceuticals Inc. | 3 | $51 |
| Organon | 3 | $37 |
| Avion Pharmaceuticals | 2 | $34 |
| Minerva Surgical, Inc | 2 | $27 |
| Roche Diagnostics Corporation | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Merck | 1 | $17 |
| BD | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$115
How this compares
Too few obstetrics providers in Louisianato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 33 | $893 |
| Alendronate Sodium | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Hammond
- Barry BieberAlexandria$18K
- Yuri SimonianNew Orleasns$6K
- Michael GrahamMetairie$5K
- Miranda WesthoffShreveport$3K
- Kristin GreenNew Orleans$2K
- Jane MillerMetairie$2K
- George MorrisHarahan$1K
- Gilbert PellerinAbbeville$1K
- Crystal NhieuBaton Rouge$1K
- Kevin StephensNew Orleans$599
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.